Traitements des facteurs de risque cardiovasculaire et dépistage de la maladie coronarienne dans le diabète de type 2 [Treatments for cardiovascular risk factors and screening for coronary artery disease in type 2 diabetes mellitus]

Détails

ID Serval
serval:BIB_7C9EB72E65CB
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Traitements des facteurs de risque cardiovasculaire et dépistage de la maladie coronarienne dans le diabète de type 2 [Treatments for cardiovascular risk factors and screening for coronary artery disease in type 2 diabetes mellitus]
Périodique
Revue Médicale Suisse
Auteur(s)
Ruiz J., Egli M., Gianinazzi F., Izzo F., Voeffray Favre A.C., Rossi I., Bodenman P.
ISSN
1660-9379[print], 1660-9379[linking]
Statut éditorial
Publié
Date de publication
2010
Volume
6
Numéro
252
Pages
1176-8, 1180-1
Langue
français
Résumé
The recent ACCORD and DIAD studies revealed results which could modify treatments and the screening of diabetes vascular complications. Indeed, ACCORD shows no benefit on the prevention of diabetes vascular complications by aggressive treatment of hypertension or the combined treatment of the dyslipidemia. The intensive treatment of the blood glucose, if associated with severe hypoglycemias, increases mortality. DIAD revealed 20% of silent myocardial ischaemia in diabetic patients but no beneficial effect on the cardiovascular mortality. A careful reading of these studies in the light of long term studies such as UKPDS and STENO reveals that these negative results are generated by a too short follow-up and too aggressive objectives. The long term studies reveal that more realistic objectives remain beneficial.
Mots-clé
Antilipemic Agents/therapeutic use, Coronary Disease/diagnosis, Coronary Disease/epidemiology, Diabetes Mellitus, Type 2/complications, Dyslipidemias/complications, Dyslipidemias/drug therapy, Evidence-Based Medicine, Humans, Hypertension/complications, Hypertension/drug therapy, Mass Screening, Procetofen/therapeutic use, Randomized Controlled Trials as Topic, Risk Factors
Pubmed
Création de la notice
01/10/2010 20:20
Dernière modification de la notice
03/03/2018 18:38
Données d'usage